Not registered yet? Please contact our project assistant Dennis Cleff . This area is only for members of the research consortium.

Nordic Bioscience A/S

Liver Fibrosis Research
Herlev Hovedgade 205-207
2730 Herlev
Visit website

Team Leader

Prof. Dr. Morten Karsdal

CEO NordicBio
Phone: +45 445 252 52
Send message

Team Staff

Dr. Diana Julie Leeming

Director of Fibrosis & Hepatology Researcher
Phone: +45 445 252 52
Send message

Dr. Alejandro M. Guiliani

Senior Scientist
Phone: +45 4452 5252
Send message

Dr. Letizia Satriano

Project Scientist
Phone: +45 4452 5225
Send message

Institute Presentation

Nordic Bioscience is dedicated to preclinical and clinical drug development, which specializes in precision medicine using biomarkers, developed using Protein Fingerprint™ technology. A given target, protein, or metabolite, which is cleaved by a specific enzyme yields neo-epitopes that are targeted by specific monoclonal antibodies.

We will use this technology to design, develop, and validate biomarker assays that can be used as companion biomarker tools to identify the patients most likely to respond to treatment. In DECISION, we will design a prognostic test and a test for response to combinatorial therapy in WP4 to be used in WP5. Nordic Bioscience will also support the exploitation, valorization, and sustainability of new intellectual property (IP) in WP7.